About SnapGene
SnapGene is a Healthcare company based in Chicago (United States) founded in 2012, and was acquired by Graphpad in August 2019. Tool for laboratory management. Its website snapgene.com draws about 196 thousand monthly visits. SnapGene offers products and services including SnapGene, SnapGene Viewer, and SnapGene Academy. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Laboratory Management. Its legal entity is GSL Biotech LLC. Its competitors include Waters Corporation, Ovation and Labvantage; 1 of its 3 listed competitors has raised funding.
Company details
SnapGene has designed tools to plan, visualize, and document molecular biology procedures. The SnapGene software is used to document cloning constructs electronically, and the following technologies enable users to design Gene cloning experiments from end to end. In-Fusion Cloning method helps to create fusion genes, whereas Gibson Assembly allows design of DNA fragments with overlapping ends for non-enzymatic insertion, the software also provides tools in PCR and mutagenesis studies. Other products include visualization software called SnapGeneViewer that allows designing of primers and probes and SnapGene server which assists websites into generating better quality genetic maps, with enhanced features.
- Headquarters Chicago, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website snapgene.com
- Social LinkedIn X Facebook
- Acquired by Graphpad (Aug 2019)
- Legal Name Gsl Biotech Llc
Products & Services of SnapGene
SnapGene offers a comprehensive portfolio of products and services, including SnapGene, SnapGene Viewer, and SnapGene Academy.
Tool for planning and simulating molecular biology procedures
Free application to view and share molecular biology data
Online platform for tutorials on molecular biology techniques
Funding Insights of SnapGene
- Total Rounds 1
- Last Round Grant — $750,000
- First Round $750,000
(Apr 2012)
- Investors Count 1
All 1 funding rounds of SnapGene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2012 | $750,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in SnapGene
SnapGene has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Graphpad.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Cloud-based data visualization and analysis tools are supplied to scientists. | 1989 | graphpad.com | San Diego, United States |
Investor details for SnapGene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SnapGene
3 dated milestones of SnapGene across 7 years, from founding to its latest funding, stage changes and deals.
- Founded SnapGene is founded.
- Funding First funding round of $750K.
- Exit Acquired by Graphpad.
Competitors of SnapGene
SnapGene has 3 listed competitors in our database, 1 of them funded. They include Waters Corporation, Ovation and Labvantage.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| waters.com | 1958 | Milford, United States | 9,341 | Provider of laboratory management system for researchers and clinicians | ||
| ovation.io | 2009 | Cambridge, United States | $33.28M | 35 | Cloud-based platform for laboratory data management and collaboration is provided. | |
| labvantage.com | 1989 | Somerset, United States | 100 | LIMS, Quality ELN and Business Intelligence solutions for laboratory |
Detailed competitors of SnapGene
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SnapGene
The website of SnapGene (snapgene.com) receives about 195.8K visits a month.
- Monthly visits195.8K
▼ 12.8% vs previous month
Websites whose visitors overlap most with SnapGene. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
addgene.org | addgene.org | 100% | #84,256 | – | |
syngene.com | syngene.com | 74% | – | ||
| benchling.com | 68% | 1.4M | #36,159 | View details | |
jingege.wang | jingege.wang | 68% | #2,694,853 | – | |
| cell.com | 65% | 5M | #14,619 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for SnapGene
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as SnapGene (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Snapgene
Complete news archive for SnapGene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SnapGene
SnapGene was founded in 2012.
SnapGene is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
SnapGene has designed tools to plan, visualize, and document molecular biology procedures. The SnapGene software is used to document cloning constructs electronically, and the following technologies enable users to design Gene cloning experiments from end to end. In-Fusion Cloning method helps to create fusion genes, whereas Gibson Assembly allows design of DNA fragments with overlapping ends for non-enzymatic insertion, the software also provides tools in PCR and mutagenesis studies. Other products include visualization software called SnapGeneViewer that allows designing of primers and probes and SnapGene server which assists websites into generating better quality genetic maps, with enhanced features.
SnapGene's top competitors include Ovation, Waters Corporation and Labvantage.
SnapGene offers SnapGene, SnapGene Viewer, and SnapGene Academy.
SnapGene operates through Gsl Biotech Llc.
Yes. SnapGene was acquired by Graphpad in August 2019.
The website of SnapGene receives about 196 thousand visits a month.

